MAPK14 and rheumatoid arthritis: Several lines of evidence have demonstrated that inhibition of ERK, p38 and NF-κB activation dampened TNF-α, IL-6, IL-8, MMP-3, MMP-13 and RNAKL expression in RA-FLS [35-38].